Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Sucampo's cobiprostone granted fast track designation for oral mucositis

May 8, 2015

Oral Health Australia reports propeptides for periodontal diseases

Dec. 12, 2014

Liquidia forms oral health company Lq3 Pharmaceuticals

Sep. 16, 2014

C3 Jian completes phase II trial of C16G2

Sep. 10, 2014

C3 Jian begins phase II study of C-16G2 for prevention of dental caries

March 10, 2014

Soligenix begins phase II trial of SGX-942 for the treatment of oral mucositis

Dec. 12, 2013

Interleukin Genetics to launch PerioPredict periodontal disease test

Nov. 28, 2013

Clinical characterization of a novel pleiotropic anti-inflammatory effect of high-dose statin

Oct. 22, 2013

Acacia Pharma's phase II trial of APD-515 for xerostomia meets primary endpoint

Oct. 15, 2013

C3 Jian completes phase I trial of therapeutic for prevention of tooth decay

Aug. 23, 2013

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...